The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Omeros Corporation(NASDAQ:OMER) 
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. ...
Website: http://www.omeros.com
Founded: 1994
Full Time Employees: 258
Sector: Healthcare
Industry: Biotechnology
Omeros Days Payable Outstanding ttm (DPO)
Omeros Days Receivable Outstanding ttm (DSO)
Omeros Op Cashflow Per Share ttm
Omeros Free Cashflow Per Share ttm
Omeros Cash Per Share ttm
Omeros P/S ratio ttm
Omeros (GAAP) P/E ratio ttm
Omeros P/B ratio ttm
No extra charts and metrics for this ticker.